ÂÜÀòÂÒÂ×

The Research and Development team at Switch Therapeutics is dedicated to advancing the CASi platform by conducting cutting-edge research in RNA discovery, medicinal chemistry, and biology. This multidisciplinary team collaborates on the design, synthesis, and evaluation of novel RNA-based therapeutics, aiming to harness the potential of nucleic acid nanotechnology to address challenging diseases of the central nervous system and other systemic indications. Their efforts focus on translating innovative scientific insights into effective treatment solutions with a strong emphasis on project management and bioanalytics.